Improving Access to Early Psychosis Coordinated Specialty Care
NCT ID: NCT04277585
Last Updated: 2021-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2019-09-27
2020-09-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhanced Coordinated Specialty Care for Early Psychosis
NCT06071858
mHealth for Psychosis Help-seeking
NCT05905601
Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2
NCT05345184
Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis
NCT00307216
Facilitating Engagement in Evidence-Based Treatment for Early Psychosis
NCT04532034
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to determine feasibility and acceptability of providing some of the services provided by OASIS via telehealth.
Participants: Up to 10 patients who have been accepted by the OASIS program and who live 45-minutes or more from the UNC OASIS program or another CSC program. Participants must also have home internet bandwidth sufficient to support the telehealth platform and own a computer or other device (smart phone, tablet, etc.) compatible with the telehealth platform.
Procedures (methods): The OASIS program does not exclude patients based on where they live in North Carolina. Potential OASIS patients and their families participate in an initial psychosocial and medical evaluation. At this time the OASIS program director reviews the OASIS program expectations with the patient and family. If the OASIS program and the patient and the patient's family member agree that the OASIS program is a good fit, the patient is then accepted into the program. After acceptance into the OASIS program patients who live 45 minutes or more away from the UNC OASIS or another CSC program and who reside in North Carolina will be informed about the availability of the telehealth pilot project by the OASIS program director.
UNCH has developed a telehealth service that is provided via the UNC electronic medical record platform, EPIC. If interested, the OASIS patient and their family member will meet with a study staff person, who will evaluate whether their internet bandwidth is sufficient to support the EPIC telehealth platform and if they own a computer or other device that supports the EPIC telehealth platform. Patients who are interested and who meet these requirements will then participate in the oral and written informed consent process.
Participants who consent to participate in the study will receive some of their CSC services via telehealth, and will continue to receive some of their services in the OASIS offices. During this pilot phase the project will be flexible about the relative proportion of services delivered via telehealth and in-person. The main study participant is the patient, however since family therapy may be delivered via telehealth interested family members are also asked to consent to study participation.
The OASIS program routinely collects quality assurance data via self-report and clinician-administered assessments. The study will obtain consent from study participants to access this information. In addition to the Quality Assurance document patients who are subjects and their family members who also consent to participate in the the telehealth pilot project will also complete a self-report survey inquiring about their satisfaction with telehealth services.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OASIS Clients
Clients of the OASIS Program who live at least 45 minutes away from an Early Psychosis Coordinated Specialty Care Program and are willing to engage in some of their services through telehealth.
Telehealth
Early Psychosis Coordinated Specialty Care Services via telehealth.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telehealth
Early Psychosis Coordinated Specialty Care Services via telehealth.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Reside in NC
* Live more than a 45 minute drive from UNC OASIS or UNC Encompass CSC programs.
* Accepted into the OASIS program.
* Have access to a computer or other device with broadband internet sufficient to support the EPIC-delivered telehealth services.
* Willing to receive some services via telehealth. A family member of a patient who is participating in this research study.
Exclusion Criteria
* Does not reside in NC
* Live within a 45 minute drive from UNC OASIS or UNC Encompass CSC programs.
* Not accepted into the OASIS program.
* No access to a computer or other device with broadband internet sufficient to support the EPIC-delivered telehealth services.
* Not willing to receive any services via telehealth
18 Years
36 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
North Carolina Department of Health and Human Services
OTHER_GOV
Substance Abuse and Mental Health Services Administration (SAMHSA)
FED
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diana Perkins, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, School of Medicine, Department of Psychiatry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OASIS Clinic
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-0048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.